Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.53 USD | +2.71% | +16.23% | +94.14% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+94.14% | 35.26M | |
+32.51% | 50.85B | |
+0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.79% | 26.11B | |
-22.20% | 19.13B | |
+8.63% | 13.05B | |
+27.25% | 12.16B | |
+24.38% | 12.08B |
- Stock Market
- Equities
- BCLI Stock
- News Brainstorm Cell Therapeutics Inc.
- Transcript : Brainstorm Cell Therapeutics Inc., Q1 2023 Earnings Call, May 15, 2023